Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)
暂无分享，去创建一个
H. Linden | G. Hortobagyi | D. Tripathy | A. Godwin | D. Hayes | R. Wenstrup | A. Hartman | K. Timms | G. Hortobagyi | H. Pathak | P. Sharma | P. Sharma | K. Isakova | D. Williams | W. Barlow | Priyanka Sharma | Dominic P. Williams | William E. Barlow | Andrew K. Godwin | Daniel F. Hayes | Kamilla Isakova | Hannah M. Linden | Debasish Tripathy | Andrew K Godwin